Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Trop Med Int Health ; 7(12): 1003-8, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12460390

ABSTRACT

OBJECTIVES: To investigate (1) benefits due to personal protection of individual net users vs. mass killing of mosquitoes within villages as a result of widespread net usage; (2) sustainability over several years of benefits against malarial morbidity of insecticide-treated nets; (3) distribution of the benefits in different age groups of children and (4) whether, as a result of fading immunity, older age groups 'paid for' the benefits which they had enjoyed when younger. METHODS: (1) Tabulation of earlier data to compare personal and community-wide effects against mosquito vectors; (2) two cross-sectional surveys for malaria parasitaemia, malarial fever, anaemia and splenomegaly in children in eight Tanzanian villages, in which there had been community-wide use of bednets which had been annually re-treated with alphacypermethrin for 3-4 years; (3) comparison between children of different age groups and with intact, torn or no nets in these villages and in 4-6 villages without nets. RESULTS: A 90-95% reduction in infective bites outside nets in netted villages and an additional 54-82% reduction of bites among individual net users. Highly significant reductions (by 55-75%) in malarial morbidity for children aged 6 months to 2 years were found in netted villages with, for some outcomes, better results among individuals who themselves had intact treated nets. For older children, benefits were less clear or absent, but there was no sign that the benefits early in life were 'paid for' by worse outcomes in the netted villages later in childhood. CONCLUSIONS: The overall benefits to the community of widespread use of treated nets are sustainable and are not reversed in 3-4 years as a result of fading immunity. It is important to ensure high enough coverage to realize the full potential of the treated net method. By showing an impact on the vector population in the community these results provide a strong argument for organized free provision of net treatment, rather than relying on marketing.


Subject(s)
Bedding and Linens , Insecticides , Malaria/prevention & control , Pyrethrins , Anemia/parasitology , Anemia/prevention & control , Child, Preschool , Cross-Sectional Studies , Humans , Infant , Logistic Models , Malaria/diagnosis , Morbidity , Mosquito Control , Odds Ratio , Parasitemia , Tanzania , Time Factors
2.
Med Vet Entomol ; 16(1): 106-8, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11963974

ABSTRACT

Adult mosquitoes, Anopheles gambiae Giles and Culex quinquefasciatus Say (Diptera: Culicidae), were exposed for 3 min to replicate samples of polyester netting cut from replicate bednets treated with pyrethroid insecticide formulations at the recommended concentration (alphacypermethrin SC at 40mg ai/m2; cyfluthrin EW at 50 mg ai/m2; deltamethrin WT at 25 mg ai/m2), or treated with only a quarter of those dosages. After 4 months domestic use of the bednets in Malawi, chemical assays showed that pyrethroid deposits on the netting were somewhat less than the target concentrations. Comparing the pyrethroid bioassay results with Anopheles at both treatment concentrations, deltamethrin gave significantly higher mortality (99.7-100%) than the other compounds (alphacypermethrin 94-96%, cyfluthrin 80-89%). Culex bioassay mortality was lower (alphacypermethrin 56-74%; cyfluthrin 63-65%; deltamethrin 50-81 %) and results with the three pyrethroid insecticides at their recommended doses did not differ significantly.


Subject(s)
Anopheles/drug effects , Culex/drug effects , Insecticides/pharmacology , Mosquito Control/methods , Pyrethrins/pharmacology , Animals , Beds , Dose-Response Relationship, Drug , Female , Male , Survival Analysis
3.
Am J Epidemiol ; 150(10): 1001-21, 1999 Nov 15.
Article in English | MEDLINE | ID: mdl-10568615

ABSTRACT

The global poliomyelitis eradication initiative has been a tremendous success, with current evidence suggesting that wild poliovirus will cease to circulate anywhere in the world soon after the year 2000. As the goal of wild poliovirus eradication is approached, concern has been raised about the potential for persistent transmission of oral polio vaccine (OPV) viruses, as these viruses are known to revert toward wild-type neurovirulence. This paper has been extracted from a document prepared for the World Health Organization on the implications of OPV transmissibility for the strategy of stopping OPV vaccination after global eradication of wild polioviruses. The authors review the empirical evidence on OPV transmissibility available from household and community transmission studies and from mass-vaccination experiences. They then consider theoretical measures of transmissibility and persistence for wild and OPV viruses (secondary attack rate, basic reproduction number, and critical populations' size), to assess whether transmissibility of OPV viruses is sufficient to allow persistence of these viruses after cessation of vaccination. The findings indicate that OPV viruses could persist under various plausible circumstances, and that this potential should be a major consideration when planning the cessation of OPV vaccination.


PIP: In view of the growing concern over the potential for persistent transmission of oral polio vaccine (OPV) viruses, this paper examines a document on the implications of OPV transmissibility for the strategy of stopping OPV vaccination after global eradication of wild polio viruses. It reviews the empirical evidence on OPV transmissibility gathered from household and community transmission studies and from mass-vaccination experiences. It assesses whether transmissibility of OPV viruses are sufficient to allow persistence of these viruses after cessation of vaccination by considering theoretical measures of transmissibility and persistence for wild and OPV viruses. This review concludes that there is a risk that OPV viruses will persist and that such persistence could occur in a variety of ways. Further research is needed to assess the implications for OPV virus persistence, especially on issues concerning the long-term excretion by immunodeficient individuals; the ability for OPV viruses to spread and persist in communities with low seroprevalence; the risk of reversion to wild-type transmissibility; environmental survival and potential reservoirs of OPV virus; duration of mucosal immunity; and the prevalence of viable poliovirus in stored samples.


Subject(s)
Global Health , Poliomyelitis/prevention & control , Poliovirus Vaccine, Oral , Poliovirus/pathogenicity , Disease Reservoirs , Humans , Poliomyelitis/transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...